Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells. (Q38131826)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells. |
scientific article |
Statements
Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells (English)